Page last updated: 2024-09-05

sk&f 99085 and Bone Neoplasms

sk&f 99085 has been researched along with Bone Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brion, R; Ebetion, FH; Heymann, D; Moriceau, G; Redini, F; Roelofs, AJ; Rogers, MJ	1

Other Studies

1 other study(ies) available for sk&f 99085 and Bone Neoplasms

Article	Year
Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth. Cancer, 2012, Feb-01, Volume: 118, Issue:3 Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Diphosphonates; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Protein Prenylation; Rats; Tumor Cells, Cultured	2012

Article

Year

Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.

Cancer, 2012, Feb-01, Volume: 118, Issue:3

Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Bone Neoplasms; Cell Cycle; Cell Proliferation; Diphosphonates; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Male; Mice; Mice, Inbred C3H; Osteosarcoma; Protein Prenylation; Rats; Tumor Cells, Cultured

2012